Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study
Clinical trial NCT07235709 · RECRUITING
Trial details
- NCT number
- NCT07235709
- Sponsor
- Yonsei University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-11-12
- Primary completion
- 2029-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.